Edith M. Lord, Ph.D.

Edith M. Lord, Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 316
Rochester, NY 14642

Professional Bio

Dr. Edith Lord is the Senior Associate Dean for Graduate Education and Postdoctoral Affairs at the School of Medicine and Dentistry. Dr. Lord received her BA degree in microbiology from the University of Kansas in 1970 and a Ph.D degree in immunology from the University of California at San Diego in 1975. She was a postdoctoral fellow at the University of California at San Francisco. Dr. Lord leads the School of Medicine and Dentistry's Ph.D., postdoctoral and master's degree programs. As a faculty member since 1976, Dr. Lord has demonstrated excellence as a scientist and dedication to her position as Senior Associate Dean.



From 2006-2008, Dr. Lord led the graduate program in the Department of Microbiology and Immunology. She also directs the school's Post-baccalaureate Research and Education Program (PREP), which encourages underrepresented minorities to pursue a research doctorate and prepares them for careers as scientists and leaders in the biomedical community.

In her research, Dr. Lord focuses on the immune responses that can control tumor development and also studies the unique microenvironment present within growing tumors. She has published, as author and co-author, more than 100 scientific articles and continues her passion for research today.

Patents

Detection of Hypoxia

United States Serial NO.: 08/286,065
Filed Date: August 4, 1994
Title: Detection of Hypoxia with Reagents Containing 2-Nitroimidazole Compounds and Methods of Making such Reagents.
Invented by: Edith Lord, Cameron Koch
Detection of Hypoxia

United States Serial NO.: 08/598,752
Filed Date: February 8, 1996
Title: Detection of Hypoxia
Invented by: Edith Lord, Cameron Koch
Human Glandular Kallikrein (hK2)-Specific Monoclonal Antibodies that Enhance or Inhibit the Enzymatic Activity of hK2

United States Serial NO.: 10/491,761
Filed Date: October 3, 2002
Title: Human Glandular Kallikrein (HK2)-Specific Monoclonal Antibodies that Enhance or Inhibit the Enzymatic Activity of HK2
Invented by: John Frelinger, Terrence Fisher, Mary Ann Nocera-March, Edith Lord

Recent Journal Articles

Showing the 5 most recent journal articles. 63 available »

2015 Jan
Gerber SA, Cummings RJ, Judge JL, Barlow ML, Nanduri J, Johnson DE, Palis J, Pentland AP, Lord EM, Ryan JL. "Interleukin-12 preserves the cutaneous physical and immunological barrier after radiation exposure." Radiation research. 2015 Jan; 183(1):72-81. Epub 2015 Jan 07.
2014 Jul
Martin DK, Uckermann O, Bertram A, Liebner C, Hendruschk S, Sitoci-Ficici KH, Schackert G, Lord EM, Temme A, Kirsch M. "Differential growth inhibition of cerebral metastases by anti-angiogenic compounds." Anticancer research. 2014 Jul; 34(7):3293-302.
2014 May 15
Gerber SA, Lim JY, Connolly KA, Sedlacek AL, Barlow ML, Murphy SP, Egilmez NK, Lord EM. "Radio-responsive tumors exhibit greater intratumoral immune activity than nonresponsive tumors." International journal of cancer. Journal international du cancer. 2014 May 15; 134(10):2383-92. Epub 2013 Nov 11.
2014 Apr 29
Xu Y, Hyun YM, Lim K, Lee H, Cummings RJ, Gerber SA, Bae S, Cho TY, Lord EM, Kim M. "Optogenetic control of chemokine receptor signal and T-cell migration." Proceedings of the National Academy of Sciences of the United States of America. 2014 Apr 29; 111(17):6371-6. Epub 2014 Apr 14.
2014
Lim JY, Brockstedt DG, Lord EM, Gerber SA. "Radiation therapy combined with Listeria monocytogenes-based cancer vaccine synergize to enhance tumor control in the B16 melanoma model." Oncoimmunology. 2014 3:e29028. Epub 2014 Jun 03.

Current Appointments

Senior Associate Dean, Graduate Education - Department of Dean's Office M&D - Administration (SMD)
Professor - Department of Microbiology and Immunology (SMD) - Primary
Professor - Cancer Center

Education

PhD | Immunology | Univ of Cal San Diego1975
BA | Microbiology | University of Kansas1970